comparemela.com

Page 13 - தேவதூதர் ரெமிரெஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

3rd Alaska health care worker experiences adverse reaction to COVID-19 vaccine

Print article Five Alaska health care workers experienced adverse reactions after getting the COVID-19 vaccine this week including two cases that were considered serious but health officials continue to emphasize that such reactions are both rare and treatable while the vast majority of vaccine recipients were fine. A Fairbanks health care worker was treated for a “probable” serious allergic reaction on Thursday after she received the COVID-19 vaccine, according to the Foundation Health Partners care system. Additionally, on Friday evening, Providence Alaska reported that two caregivers who received the COVID-19 vaccine experienced non-life-threatening, mild reactions. Those incidents follow reactions experienced by two Bartlett Regional Hospital employees in Juneau one serious and one mild after they were vaccinated earlier in the week.

2nd reported severe reaction to COVID-19 vaccine

.... .... .... .... .... .... .... .... .... .... .... .... .... .... .... .... .... .... SEOUL, South Korea Long lines are snaking from coronavirus testing sites in the South Korean capital of Seoul on Saturday as the country reports 1,053 more confirmed cases, the fourth straight day over 1,000. Thousands are taking advantage of free tests being offered temporarily in the capital area. The government is struggling to decide whether to increase social distancing to maximum levels, which officials fear would further shock the economy. The new cases brought the national caseload to 48,570. Nearly 7,000 of those cases have been added over the past week. ...................... Fourteen COVID-19 patients died in the past 24 hours to bring the death toll to 659. There are concerns fatalities will continue to rise because of a shortage of intensive care beds in the Seoul area, which is being hit hardest by the virus.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.